Skip to content

Micreos vs PolyPid Ltd.

Micreos  logo

Micreos

Micreos is a biotech company focused on discovering and developing recombinant technology

21 employees · est. 2022 · Baar, Switzerland

VS
PolyPid Ltd.  logo

PolyPid Ltd.

Controlled, extended-release, local delivery of medication at effective release rates over predetermined durations

66 employees · est. 2008 · Israel

PolyPid Ltd. is the older company (2022 vs 2008); PolyPid Ltd. is the larger of the two.

Side-by-Side Comparison

Micreos PolyPid Ltd.
Founded
2022 2008 older
Headquarters
Baar, Switzerland Israel
Employees
21 66 larger
Industry
Biotechnology, Design, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Venture round Post-IPO Equity
Total Funding
$59.50M $139.80M
Funding Rounds
4 7
Taxonomy
Biotech CompanyRecombinant ProteinsClinical-stage PharmaceuticalAntimicrobial ResistanceEndolysin-based Investigational AntimicrobialsDermatology +7 Bio-pharmaceuticalSurgical TherapiesDrug DeliveryLocal MedicationPolymer-Lipid Encapsulation MatriXSurgical Site Infections +5
Website
micreos.com polypid.com
Micreos  logo

About Micreos

Micreos is a platform biotech company founded in 2006, with its headquarters in Switzerland. The company focuses on discovering and developing recombinant proteins for chronic Dermatology and Oncology conditions. Micreos is making strides in clinical-stage pharmaceutical biotech, with a vision to po...

PolyPid Ltd.  logo

About PolyPid Ltd.

PolyPid Ltd. is a global clinical-stage bio-pharmaceutical company with a focus on developing, manufacturing, and commercializing novel therapies for surgical outcomes. The company's PLEX (Polymer-Lipid Encapsulation matriX) technology is designed to provide controlled and continuous delivery of med...

Also comparing in this category

Comparing more than these two?

Get Micreos , PolyPid Ltd. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Micreos compare?

A PDF of Micreos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Micreos was founded in 2022, based in Baar, Switzerland, with 21 employees. Micreos is a platform biotech company founded in 2006, with its headquarters in Switzerland. The company focuses on discovering and developing recombinant proteins for chronic Dermatology and Oncology. PolyPid Ltd. was founded in 2008, based in Israel, with 66 employees. PolyPid Ltd. is a global clinical-stage bio-pharmaceutical company with a focus on developing, manufacturing, and commercializing novel therapies for surgical outcomes. The company's PLEX (Polymer-Lip.
Micreos has raised $59.50M and PolyPid Ltd. $139.80M. Latest stage: Micreos Venture round, PolyPid Ltd. Post-IPO Equity.
Both work in Biotechnology and Health Care and list antibiotic resistance among their focus areas.

Compare Micreos with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Micreos on 12 Sep 2024, and PolyPid Ltd. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout